These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3007319)

  • 1. Models of hepatic elimination.
    Weisiger RA
    Hepatology; 1986; 6(2):338-40. PubMed ID: 3007319
    [No Abstract]   [Full Text] [Related]  

  • 2. A carrier-protein receptor is not a prerequisite for avid hepatic elimination of highly bound compounds: a study of propranolol elimination by the isolated perfused rat liver.
    Jones DB; Ching MS; Smallwood RA; Morgan DJ
    Hepatology; 1985; 5(4):590-3. PubMed ID: 2991106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of substrate elimination by the liver: has the albumin receptor model superseded the well-stirred model?
    Morgan DJ; Jones DB; Smallwood RA
    Hepatology; 1985; 5(6):1231-5. PubMed ID: 2998965
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presystemic elimination and mean residence time.
    Brockmeier D
    Biopharm Drug Dispos; 1985; 6(2):229-30. PubMed ID: 4005399
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired drug metabolism in experimental cirrhosis in the rat.
    Villeneuve JP; Wood AJ; Shand DG; Rogers L; Branch RA
    Biochem Pharmacol; 1978; 27(22):2577-81. PubMed ID: 728210
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug metabolism in rats bearing a pituitary mammotropic tumor.
    Villeneuve JP; Gerber JG; Branch RA; Shand DG; Wilson JT
    J Pharmacol Exp Ther; 1979 Apr; 209(1):7-11. PubMed ID: 430380
    [No Abstract]   [Full Text] [Related]  

  • 9. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of hepatic drug elimination.
    Bass L
    J Pharm Sci; 1983 Oct; 72(10):1229-30. PubMed ID: 6644582
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of marker drugs to measure organ function: a theoretical interpretation.
    Cobby J; Makoid MC
    Eur J Clin Pharmacol; 1980 Nov; 18(6):511-6. PubMed ID: 7461018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic elimination--dispersion model.
    Roberts MS; Rowland M
    J Pharm Sci; 1985 May; 74(5):585-7. PubMed ID: 4020641
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow.
    Reilly CS; Wood AJ; Koshakji RP; Wood M
    Anesthesiology; 1985 Jul; 63(1):70-6. PubMed ID: 4014773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.
    Weisiger R; Gollan J; Ockner R
    Science; 1981 Mar; 211(4486):1048-51. PubMed ID: 6258226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of an albumin receptor in hepatic organic anion uptake: the controversy continues.
    Wolkoff AW
    Hepatology; 1987; 7(4):777-9. PubMed ID: 3038726
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic uptake of albumin-bound substances: albumin receptor concept.
    Ockner RK; Weisiger RA; Gollan JL
    Am J Physiol; 1983 Jul; 245(1):G13-8. PubMed ID: 6307061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol metabolism by isolated hepatocytes from normal and cirrhotic rat livers: the effect of albumin.
    Gariepy L; Fenyves D; Petit JL; Raymond G; Villeneuve JP
    Can J Physiol Pharmacol; 1990 Jun; 68(6):657-62. PubMed ID: 2164869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AUTOMOD: a polyalgorithm for an integrated analysis of linear pharmacokinetic models.
    Gomeni R; Gomeni C
    Comput Biol Med; 1979; 9(1):39-48. PubMed ID: 421435
    [No Abstract]   [Full Text] [Related]  

  • 19. The hepatic first-pass metabolism of problematic drugs.
    Lalka D; Griffith RK; Cronenberger CL
    J Clin Pharmacol; 1993 Jul; 33(7):657-69. PubMed ID: 8366191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
    Iwamoto K; Watanabe J
    J Pharm Pharmacol; 1985 Nov; 37(11):826-8. PubMed ID: 2867168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.